FLUNET compounds (Biota)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameFLUNET compounds (Biota)
Drug Alias NameFLUNET compounds (Biota/ Daiichi Sankyo)FLUNET compounds (Biota/Sankyo)dimeric zanamivir (Biota/GSK)FLUNET compounds (Biota/GSK)dimeric zanamivir (Biota/Sankyo) +[12] 
ClassificationSmall molecules
Mechanisms of ActionVirus replication inhibitorsNeuraminidase inhibitors
TargetsNeuraminidase
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandUnited KingdomJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiota Holdings Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiota Holdings LtdGlaxosmithkline PlcGlaxo Group Ltd +[6] 
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A